Fair Isaac Other Income (Expense) decreased by 1558.0% to -$1.86M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 48.1%, from -$1.25M to -$1.86M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 13.7% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.53M | $771.00K | $1.43M | -$2.36M | -$1.00M | -$206.00K | $364.00K | $1.61M | $5.30M | $3.39M | $3.99M | $3.94M | $2.72M | $89.00K | -$1.25M | $7.37M | $5.19M | -$112.00K | -$1.86M |
| QoQ Change | — | -78.1% | +85.3% | -265.2% | +57.6% | +79.4% | +276.7% | +340.9% | +230.3% | -36.0% | +17.5% | -1.3% | -30.9% | -96.7% | <-999% | +687.9% | -29.7% | -102.2% | <-999% |
| YoY Change | — | — | — | — | -128.4% | -126.7% | -74.5% | +168.0% | +630.1% | +832.1% | +148.3% | -25.8% | — | -97.4% | -131.5% | +87.3% | +90.6% | -225.8% | -48.1% |